Lupin to invest $250 million in new US pharma plant in Coral Springs, Florida

The project involves a cumulative investment of $250 million over five years, covering research and development, infrastructure, and capital expenditures. Shares of Lupin Ltd ended at ₹1,902.80, down by ₹22.00, or 1.14%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *